查看购物车
  • Traditional Chinese
  • English
封面
市场调查报告书
商品编码
1684425

呼吸系统疾病检测市场，按产品、按应用、按最终用户、按国家和地区 - 2025 年至 2032 年的行业分析、市场规模、市场份额和预测

Respiratory Disease Testing Market, By Product, By Application, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 322 Pages | 商品交期: 2-3个工作天内

价格
简介目录

报告重点

2024 年呼吸疾病检测市场规模价值为 65.9043 亿美元，2025 年至 2032 年期间的复合年增长率为 2.99%。

呼吸系统疾病检测市场-市场动态

传染性呼吸道疾病的日益普及和数位融合的不断提升预计将推动市场需求

由于呼吸系统疾病发病率上升和技术进步等多种因素，呼吸系统疾病检测市场预计将大幅成长。气喘、慢性阻塞性肺病（COPD）、间质性肺病等慢性呼吸道疾病发生率不断上升。根据世界卫生组织 (WHO) 的数据，慢性阻塞性肺病 (COPD) 是全球主要死亡原因之一，气喘影响全球数亿人。此外，RT-PCR等快速检测方法已家喻户晓，诊断实验室也扩大了其侦测能力。

此外，分子诊断、聚合酶链反应（PCR）测试和下一代定序（NGS）等新技术提高了呼吸道疾病检测的敏感性和特异性。便携式快速诊断工具的出现使得呼吸系统疾病的检测变得更加容易。这些设备在偏远地区和紧急情况下特别有用。人工智慧（AI）和机器学习（ML）正在融入诊断过程，以提高速度和准确性。人工智慧工具正在帮助解释胸部X光片和CT扫描等影像学检查。此外，先进诊断工具成本高以及医疗保健机会不平等，这些问题促使远距医疗和低成本测试解决方案等创新，进一步推动成长。

呼吸系统疾病检测市场-关键见解

根据我们的研究分析师的分析，预测期内（2025-2032 年），全球市场预计年复合成长率约为 2.99%

根据产品细分，由于 X 光成像的普及，预计成像测试领域将在 2024 年占据最大的市场份额。

根据应用细分，由于结核病患者病率高且需要诊断，结核病领域成为 2024 年领先的应用领域。

根据最终用户细分，由于 X 光机等先进医疗设备的采用率不断提高，医院部门将成为 2024 年领先的最终用户部门。

按地区划分，由于气喘和其他呼吸系统疾病的盛行率高，北美将成为 2024 年的主要收入来源。

呼吸系统疾病检测市场-細項分析：

全球呼吸系统疾病检测市场根据产品、应用、最终用户和地区进行细分。

根据产品，市场分为四大类：影像测试、血液气体测试、呼吸测量设备和其他。影像测试领域占据市场主导地位。 X光机和3D成像平台等先进成像设备的广泛采用正在推动该领域的成长。

根据应用，市场分为五类：肺癌、肺结核、气喘、慢性阻塞性肺病 (COPD) 和其他。预计结核病领域将占据最大份额。由于预防性诊断护理的需求，预计预测期内肺癌部分将以最快的速度成长。

根据最终用户，市场分为三类：医院、临床实验室和其他。医院部门在最终用户部门中占有最大的份额。呼吸系统疾病的发生率不断上升，以及患者对使用先进设备进行诊断的需求不断增加，这促进了该领域的需求。

呼吸系统疾病检测市场-地理洞察

在全球范围内，呼吸系统疾病检测市场广泛分布于北美、拉丁美洲、欧洲、亚太地区以及中东和非洲地区。北美凭藉其先进的医疗保健基础设施、先进诊断方法的高度采用以及强大的研发投入，在全球呼吸系统疾病检测市场中占有相当大的份额。根据美国肺臟协会的数据，2023 年约有 1,600 万美国人被诊断出患有 COPD。由于患者人数众多、医疗保健基础设施不断改善以及投资增加，预计亚太地区将见证呼吸疾病检测市场的最高成长。中国和印度等国家由于污染、吸烟等原因，结核病、慢性阻塞性肺病和其他呼吸道感染的发生率很高。

呼吸系统疾病检测市场-竞争格局：

呼吸系统疾病检测市场竞争激烈，全球、区域和新兴参与者提供一系列诊断解决方案。对先进、准确、快速的测试方法的需求加剧了竞争。在新兴经济体中，新创公司和小型公司正在透过推出便携且经济高效的解决方案来促进创新。市场参与者也关注结核病和肺炎等呼吸道感染的微生物学和分子诊断。公司积极致力于研发，推出创新的诊断解决方案，满足医疗保健提供者和患者不断变化的需求。

最新动态：

2024年10月，Quest Diagnostics宣布推出H5N1禽流感检测，以增强公司的产品组合。

2024 年 10 月，牛津奈米孔公司与 NHS England 合作，加速新病原体的筛检。

目录

第 1 章：呼吸系统疾病检测市场概述

  • 研究范围
  • 市场估计年限

第 2 章：执行摘要

  • 市场片段
    • 呼吸系统疾病检测市场产品片段
    • 呼吸系统疾病检测市场片段（按应用）
    • 呼吸系统疾病检测市场片段（按最终用户）
    • 呼吸系统疾病检测市场（按国家/地区）
    • 呼吸系统疾病检测市场片段（按地区）
  • 竞争洞察

第 3 章：呼吸系统疾病检测主要市场趋势

  • 呼吸系统疾病检测市场驱动因素
    • 市场驱动因素的影响分析
  • 呼吸系统疾病检测市场限制
    • 市场限制的影响分析
  • 呼吸系统疾病检测市场机会
  • 呼吸系统疾病检测市场未来趋势

第 4 章：呼吸系统疾病检测产业研究

  • PEST分析
  • 波特五力分析
  • 成长前景规划
  • 规范架构分析

第五章：呼吸系统疾病检测市场：地缘政治紧张局势升级的影响

  • 新冠肺炎疫情的影响
  • 俄乌战争的影响
  • 中东衝突的影响

第 6 章：呼吸系统疾病侦测市场格局

  • 2024 年呼吸系统疾病检测市场占有率分析
  • 按主要製造商分類的细分数据
    • 成熟玩家分析
    • 新兴企业分析

第 7 章：呼吸系统疾病检测市场 - 按产品

  • 概述
    • 按产品细分的份额分析
    • 影像学检查
    • 血气检查
    • 呼吸测量设备
    • 其他的

第 8 章：呼吸系统疾病检测市场 - 按应用

  • 概述
    • 按应用细分市场占有率分析
    • 肺癌
    • 结核
    • 气喘
    • 慢性阻塞性肺病（COPD）
    • 其他的

第 9 章：呼吸系统疾病检测市场 - 按最终用户

  • 概述
    • 按最终用户细分的份额分析
    • 医院
    • 临床实验室
    • 其他的

第 10 章：呼吸系统疾病检测市场 - 按地区划分

  • 介绍
    • 按地区分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 北美呼吸系统疾病检测主要製造商
    • 北美市场规模及预测（按国家/地区）
    • 北美市场规模及预测（按产品划分）
    • 北美市场规模与预测，按应用划分
    • 北美市场规模和预测（按最终用户）
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲呼吸道疾病检测主要製造商
    • 欧洲市场规模及预测（按国家）
    • 欧洲市场规模及预测（依产品划分）
    • 欧洲市场规模和预测，按应用
    • 欧洲市场规模和预测（按最终用户）
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 荷兰
    • 瑞典
    • 俄罗斯
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 亚太地区呼吸道疾病检测主要製造商
    • 亚太地区市场规模及预测（依国家/地区划分）
    • 亚太地区市场规模及预测（依产品划分）
    • 亚太地区市场规模及预测（按应用划分）
    • 亚太地区市场规模及预测（依最终用户）
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲
    • 印尼
    • 泰国
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲 (LATAM)
    • 概述
    • 拉丁美洲呼吸道疾病检测主要製造商
    • 拉丁美洲市场规模及预测（按国家/地区）
    • 拉丁美洲市场规模及预测（按产品划分）
    • 拉丁美洲市场规模及预测（按应用划分）
    • 拉丁美洲市场规模及预测（按最终用户）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲 (MEA)
    • 概述
    • 中东和非洲呼吸系统疾病检测主要製造商
    • MEA 市场规模及预测（依国家/地区划分）
    • MEA 市场规模及预测（依产品划分）
    • MEA 市场规模及预测（按应用）
    • MEA 市场规模和预测（按最终用户）
    • 沙乌地阿拉伯
    • 阿联酋
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 其他地区

第 11 章：主要供应商分析-呼吸系统疾病检测产业

  • 竞争仪錶板
    • Competitive Benchmarking
    • Competitive Positioning
  • 公司简介
    • Thermo Fisher Scientific Inc.
    • Abbott Laboratories
    • F. Hoffmann-La Roche AG
    • Siemens Healthineers
    • Becton, Dickinson and Company (BD)
    • bioMerieux SA
    • Quest Diagnostics Incorporated
    • Danaher Corporation
    • PerkinElmer Inc.
    • MGC Diagnostics Corporation
    • Oxford Nanopore
    • Agilent Technologies, Inc.
    • Vyaire Medical, Inc.
    • Philips Healthcare
    • GE HealthCare Technologies In
    • Others

第 12 章：360 度分析师视角

第 13 章：附录

  • 研究方法
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
简介目录
Product Code: ANV4786

REPORT HIGHLIGHT

Respiratory Disease Testing Market size was valued at USD 6,590.43 Million in 2024, expanding at a CAGR of 2.99% from 2025 to 2032.

Respiratory disease testing is used in diagnostic procedures to detect, evaluate, and monitor diseases affecting the respiratory system, which includes the lungs, airways, and other structures involved in breathing. These tests help identify conditions such as asthma, chronic obstructive pulmonary disease (COPD), pneumonia, tuberculosis, lung cancer, and infections like COVID-19 virus.

Respiratory Disease Testing Market- Market Dynamics

Growing prevalence of infectious respiratory diseases and rising digital integration are expected to propel market demand

The respiratory disease testing market has is expected to witness substantial growth due to a combination of factors, including the rising prevalence of respiratory illnesses, and technological advancements. Chronic respiratory diseases such as asthma, chronic obstructive pulmonary disease (COPD), and interstitial lung diseases are on the rise. According to the World Health Organization (WHO), COPD is among the leading causes of death worldwide, and asthma affects hundreds of millions worldwide. Further, rapid testing methods like RT-PCR became household terms, and diagnostic labs expanded their capacity.

Furthermore, New techniques, such as molecular diagnostics, polymerase chain reaction (PCR) tests, and next-generation sequencing (NGS), have improved the sensitivity and specificity of respiratory disease detection. The availability of portable and rapid diagnostic tools has made respiratory disease testing more accessible. These devices are particularly beneficial in remote areas and emergency scenarios. Artificial intelligence (AI) and machine learning (ML) are being integrated into diagnostic processes to enhance speed and accuracy. AI-powered tools are aiding in the interpretation of imaging tests like chest X-rays and CT scans. Moreover, high costs of advanced diagnostic tools and disparities in healthcare access, these issues have prompted innovations like telemedicine and low-cost testing solutions, further driving growth.

Respiratory Disease Testing Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 2.99% over the forecast period (2025-2032)

Based on Product segmentation, the imaging tests segment was predicted to show maximum market share in the year 2024, due to increased adoption of X-ray imaging.

Based on Application segmentation, the tuberculosis segment was the leading Application segment in 2024, due to high prevalence of tuberculosis and need for diagnosis.

Based on End User segmentation, the hospitals segment was the leading End User segment in 2024, due to increasing adoption of advanced medical devices like X-ray machines.

On the basis of region, North America was the leading revenue generator in 2024, owing to high prevalence of asthma, and other respiratory diseases.

Respiratory Disease Testing Market- Segmentation Analysis:

The Global Respiratory Disease Testing Market is segmented on the basis of Product, Application, End User, and Region.

The market is divided into four categories based on Product: imaging tests, blood gas test, respiratory measurement devices, and others. The imaging tests segment dominates the market. High adoption of advanced imaging devices like X-ray machines and 3D imaging platforms are fueling segment growth.

The market is divided into five categories based on the Application: lung cancer, tuberculosis, asthma, chronic obstructive pulmonary disease (COPD), and others. The tuberculosis segment is expected to hold the largest share. The lung cancer segment is estimated to grow at the fastest rate during the forecast period, due to the need for preventive diagnosis care.

The market is divided into three categories based on End User: hospitals, clinical laboratories, and others. The hospitals segment holds the largest share in the End User segment. The growing prevalence of respiratory diseases, and high need for patient diagnosis with advanced devices is contributing to segment demand.

Respiratory Disease Testing Market- Geographical Insights

Across the world, the Respiratory Disease Testing market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. North America holds a significant share of the global respiratory disease testing market due to its advanced healthcare infrastructure, high adoption of advanced diagnostics, and strong R&D investments. According to the American Lung Association, approximately 16 million Americans are diagnosed with COPD in 2023. The Asia-Pacific region is expected to witness the highest growth in the respiratory disease testing market due to a large patient population, improving healthcare infrastructure, and increased investments. Countries like China and India have high rates of tuberculosis (TB), COPD, and other respiratory infections due to pollution, smoking, etc.

Respiratory Disease Testing Market- Competitive Landscape:

The respiratory disease testing market is highly competitive, with the presence of global, regional, and emerging players offering a range of diagnostic solutions. Competition is fueled by the need for advanced, accurate, and rapid testing methods. In emerging economies, startups and smaller firms are contributing to innovation by introducing portable and cost-effective solutions. Market players also focus on microbiology and molecular diagnostics for respiratory infections like tuberculosis and pneumonia. Companies are actively engaged in research and development to introduce innovative diagnostic solutions to meet the evolving needs of healthcare providers and patients.

Recent Developments:

In October 2024, Quest Diagnostics announced the launch of a test for the H5N1 bird flu, to enhance the company's portfolio.

In October 2024, Oxford Nanopore partnered with NHS England to expedite the screening of new pathogens.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL RESPIRATORY DISEASE TESTING MARKET KEY PLAYERS

  • Thermo Fisher Scientific Inc.
  • Abbott Laboratories
  • F. Hoffmann-La Roche AG
  • Siemens Healthineers
  • Becton, Dickinson and Company (BD)
  • bioMerieux SA
  • Quest Diagnostics Incorporated
  • Danaher Corporation
  • PerkinElmer Inc.
  • MGC Diagnostics Corporation
  • Oxford Nanopore
  • Agilent Technologies, Inc.
  • Vyaire Medical, Inc.
  • Philips Healthcare
  • GE HealthCare Technologies Inc.
  • Others

GLOBAL RESPIRATORY DISEASE TESTING MARKET, BY PRODUCT- MARKET ANALYSIS, 2019-2032

  • Imaging tests
  • Blood gas test
  • Respiratory measurement devices
  • Others

GLOBAL RESPIRATORY DISEASE TESTING MARKET, BY APPLICATION- MARKET ANALYSIS, 2019-2032

  • Lung cancer
  • Tuberculosis
  • Asthma
  • Chronic obstructive pulmonary disease (COPD)
  • Others

GLOBAL RESPIRATORY DISEASE TESTING MARKET, BY END USER- MARKET ANALYSIS, 2019-2032

  • Hospitals
  • Clinical Laboratories
  • Others

GLOBAL RESPIRATORY DISEASE TESTING MARKET, BY REGION- MARKET ANALYSIS, 2019-2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Respiratory Disease Testing Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Respiratory Disease Testing Market Snippet by Product
    • 2.1.2. Respiratory Disease Testing Market Snippet by Application
    • 2.1.3. Respiratory Disease Testing Market Snippet by End User
    • 2.1.4. Respiratory Disease Testing Market Snippet by Country
    • 2.1.5. Respiratory Disease Testing Market Snippet by Region
  • 2.2. Competitive Insights

3. Respiratory Disease Testing Key Market Trends

  • 3.1. Respiratory Disease Testing Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Respiratory Disease Testing Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Respiratory Disease Testing Market Opportunities
  • 3.4. Respiratory Disease Testing Market Future Trends

4. Respiratory Disease Testing Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Respiratory Disease Testing Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Respiratory Disease Testing Market Landscape

  • 6.1. Respiratory Disease Testing Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Respiratory Disease Testing Market - By Product

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product, 2024 & 2032 (%)
    • 7.1.2. Imaging tests
    • 7.1.3. Blood gas test
    • 7.1.4. Respiratory measurement devices
    • 7.1.5. Others

8. Respiratory Disease Testing Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
    • 8.1.2. Lung cancer
    • 8.1.3. Tuberculosis
    • 8.1.4. Asthma
    • 8.1.5. Chronic obstructive pulmonary disease (COPD)
    • 8.1.6. Others

9. Respiratory Disease Testing Market - By End User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End User, 2024 & 2032 (%)
    • 9.1.2. Hospitals
    • 9.1.3. Clinical Laboratories
    • 9.1.4. Others

10. Respiratory Disease Testing Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Respiratory Disease Testing Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Respiratory Disease Testing Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.8. UK
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. UK Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.8.4. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.8.5. UK Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.9. France
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. France Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.9.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.9.5. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.10. Italy
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. Italy Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.10.4. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.10.5. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.11. Spain
      • 10.3.11.1. Overview
      • 10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.3. Spain Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.11.5. Spain Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.12. The Netherlands
      • 10.3.12.1. Overview
      • 10.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.3. The Netherlands Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.12.4. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.12.5. The Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Overview
      • 10.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.13.5. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.14. Russia
      • 10.3.14.1. Overview
      • 10.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.3. Russia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.14.5. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.15. Poland
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Poland Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.16. Rest of Europe
      • 10.3.16.1. Overview
      • 10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.16.3. Rest of the Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.16.4. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.16.5. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Respiratory Disease Testing Key Manufacturers in Asia Pacific
    • 10.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.4.5. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.6. APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.7. China
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. China Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.7.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.7.5. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.8. India
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. India Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.8.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.8.5. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.12. Indonesia
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Indonesia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.13. Thailand
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Thailand Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.5. Latin America (LATAM)
    • 10.5.1. Overview
    • 10.5.2. Respiratory Disease Testing Key Manufacturers in Latin America
    • 10.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.5.5. LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.6. LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa (MEA)
    • 10.6.1. Overview
    • 10.6.2. Respiratory Disease Testing Key Manufacturers in Middle East and Africa
    • 10.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. MEA Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.6.5. MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.6. MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.8. UAE
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. UAE Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.8.4. UAE Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.8.5. UAE Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Respiratory Disease Testing Industry

  • 11.1. Competitive Dashboard
    • 11.1.1. Competitive Benchmarking
    • 11.1.2. Competitive Positioning
  • 11.2. Company Profiles
    • 11.2.1. Thermo Fisher Scientific Inc.
    • 11.2.2. Abbott Laboratories
    • 11.2.3. F. Hoffmann-La Roche AG
    • 11.2.4. Siemens Healthineers
    • 11.2.5. Becton, Dickinson and Company (BD)
    • 11.2.6. bioMerieux SA
    • 11.2.7. Quest Diagnostics Incorporated
    • 11.2.8. Danaher Corporation
    • 11.2.9. PerkinElmer Inc.
    • 11.2.10. MGC Diagnostics Corporation
    • 11.2.11. Oxford Nanopore
    • 11.2.12. Agilent Technologies, Inc.
    • 11.2.13. Vyaire Medical, Inc.
    • 11.2.14. Philips Healthcare
    • 11.2.15. GE HealthCare Technologies In
    • 11.2.16. Others

12. 360 Degree AnalystView

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us